Loading viewer...
earnings
Format: PDF earnings
Seagen presents fourth quarter and full year 2022 financial results and business updates, including commercial performance of key oncology products ADCETRIS, PADCEV, TUKYSA, and TIVDAK. The presentation covers financial performance, research and development progress, and 2023 outlook with anticipated product sales, regulatory milestones, and clinical trial activities.
earnings
30 Pages
New York Mortgage Trust
Tractor Supply Q2 2023 Financial Presentation
earningsearnings
13 Pages
Tractor Supply Company
Universal Robina Q1 2024 Earnings Investor Briefing
earningsearnings
20 Pages
Universal Robina Corporation
Al Faleh Educational Holding Q4 2025 Earnings Conference Call
earningsearnings
1 Pages
Al Faleh Educational Holding